PFE 241018 29.00P (PFE241018P29000) Stock Options, News & Quotes

0.08
-0.14-63.64%

15min DelayTrading Oct 15 11:39 ET

0.23High0.05Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Deep Sea

1 hour ago

$Pfizer (PFE.US)$
The current stock price is trading above 5EMA, 10EMA and 20EMA. The trend is likely to be up. RSI has turned up too. The stock price is trading above the mid band and may be heading towards the upper band 30.04. The stock has turned bullish due to the upcoming meeting between the activist investor, Starboard Value, and Pfizer CEO on 16 Oct, Wednesday.

Deep Sea

1 hour ago

$Pfizer (PFE.US)$
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Mortimer "Tim" Buckley served as Vanguard's chairman and chief executive until this year when he announced his retirement. Buckley is 55.

Sera

2 hours ago

$Pfizer (PFE.US)$ 👍👍👍

CNNT

3 hours ago

Chart Talks: Pfizer

After a dramatic covid performance, 's share price is back to its pre-covid level and is finally showing some signs of potential upward momentum - MACD moving up and price bouncing within the upper bollinger band.
Let's take a closer look. Compared to the 2 previous small peaks, there is a trading volume decline and a neutral RSI indicator (low volitility, neither overbought nor oversold). There are no signals for up or down trend here.
Trendline also does not give a clear ...

Meltyy

9 hours ago

1 PDUFA & 1 AdCom left in October 🗓️

See FDA PDUFA update 👇
$Iterum Therapeutics (ITRM.US)$ : 🤔
⇨ Oral Sulopenem
‣ Uncomplicated Urinary Tract Infections
‣ PDUFA: 10/25/24
$Lexicon Pharmaceuticals (LXRX.US)$ : [Adcom] 🤔
⇨ ZYNQUISTA (sotagliflozin)
‣ Type 1 Diabetes
‣ Adcom: 10/31/24
📣 Last Week’s PDUFA Decisions:
$ZLDPF: CRL 10/8 ❌
⚠️ due to timing of a 3rd-party mfg. facility reinspection
⇨ Dasiglucagon
‣ Congenital Hyperinsulinism
‣ PDUFA: 10/08/24 (NDA)
$RRBHY: Approved 10/11 ✅
⇨ Itovebi™ (inavolis...